Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, noviembre 17
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Quantum BioPharma Ltd
QNTM
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$1.59
0.15
10.42%
al cierre: Nov 17, 4:00 PM EST
$1.44
-0.15
-9.43%
After hour: 8:34 AM EST
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Comparar
Informe de acciones
Ganancias:
Los beneficios de Q3 2026 se publicaron el jue nov 12th, antes de la apertura del mercado
Quantum BioPharma Financials
Quantum BioPharma (QNTM) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Top Wall Street Forecasters Revamp Thermo Fisher Scientific Expectations Ahead Of Q3 Earnings
Thermo Fisher reports Q3 earnings Oct. 21, with analysts expecting $6.40 EPS and $11.93B revenue; analysts remain bullish, raising price targets.
Avi Kapoor
PRO
Quantum BioPharma Q4 EPS $(0.71) Beats $(0.93) Estimate
Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.93) by 23.66 percent. This is a 65.53 percent increase over losses of $(2.06) per share from
Benzinga Newsdesk
PRO
Quantum BioPharma Q3 EPS $(1.25) Misses $(0.08) Estimate
Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of $(0.08) by 1462.5 percent. This is a 71.4 percent increase over losses of $(4.37) per share
Benzinga Newsdesk
PRO
Quantum BioPharma Q2 EPS $(3.23) Compared With $(0.08) YoY
Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(3.23) per share which missed the analyst consensus estimate of $(0.07) by 4514.29 percent. This is a 3937.5 percent decrease over losses of $(0.08) per share
Benzinga Newsdesk
Earnings Scheduled For May 6, 2025
Benzinga Insights
Dow Edges Higher; US Weekly Jobless Claims Increase
Avi Kapoor